Fact CheckerSign in

NCT07702968Recruiting

Low-Field MRI in Stroke Code Patients

Validation of Low Field MRI in Patients With Stroke Symptoms Less Than 12 Hours

Source: ClinicalTrials.gov · Last updated 16 Jul 2026

Brief summary (registry, in English)

This study evaluates the accuracy and feasibility of a portable low-field MRI (Hyperfine) device in patients presenting to the emergency department with suspected acute stroke. All enrolled patients undergo standard clinical imaging (CT, CT angiography, CT perfusion) and additionally receive a low-field MRI scan. Low-field MRI findings are compared to routine CT imaging and final clinical diagnosis. The study aims to determine whether low-field MRI can reliably detect acute ischemic stroke (including lacunar and large vessel occlusion), hemorrhagic stroke, and stroke mimics in the acute setting. Secondary outcomes include feasibility measures such as scan time, completion rate, patient satisfaction, and adverse events.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
3 Jul 2026
Start date
20 Apr 2026
Primary completion date
1 Apr 2027
Lead sponsor
Leiden University Medical Center
Diseases
Stroke
NCT number
NCT07702968

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 20 Apr 2026 to the primary completion date, 1 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of MRI-incompatible implanted devices (e.g., pacemaker, cochlear implant, insulin pump)

Other illness

  • Acute life-threatening or disabling condition requiring immediate intervention that precludes study procedures
  • Any study-related delay that could interfere with time-critical stroke treatments (intravenous thrombolysis or endovascular thrombectomy)

Other

  • Imminent death
  • Severe claustrophobia preventing MRI
  • Known intra-ocular metallic foreign body or intracranial metallic clip/device identified on admission CT
  • Pregnancy

Who the study is looking for

  • Age ≥ 18 years
  • Presentation with suspected acute stroke (stroke code activation by ambulance paramedics)
  • Symptom onset \< 12 hours prior to presentation
  • Admission to the emergency department of the Leiden University Medical Center (LUMC) during office hours
  • Undergoing standard-of-care head CT imaging at the emergency department
  • Ability to provide informed consent (written or verbal in the acute setting, with deferred written consent if applicable)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Leiden University Medical Center
Coordinator of this site? Confirm its status
LeidenNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.